SciELO - Scientific Electronic Library Online

 
vol.79 número2Gutiérrez-Noriega y el debate en torno al consumo de las hojas de coca: 1937-1952 índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Anales de la Facultad de Medicina

versión impresa ISSN 1025-5583

Resumen

SUAREZ, Victor et al. Prioritization for the development of clinical practice guidelines in the Seguro Social de Salud del Peru (EsSalud): multicriteria analysis. An. Fac. med. [online]. 2018, vol.79, n.2, pp.175-180. ISSN 1025-5583.  http://dx.doi.org/10.15381/anales.v79i2.14946.

Objectives. To describe the prioritization process for developing the clinical practice guidelines (GPC) in the Seguro Social del Peru (EsSalud). Methods. The prioritization process was carried out through a multicriteria analysis in three steps: identify the variables, obtain information from them and assign them a weighting. Finally, an ordered list was obtained that was put to the consideration of the policy makers. Results. The five diseases with the highest number of DALY (disability adjusted life year) were osteoarthritis, glaucoma, schizophrenia, osteoporosis and pathological fractures, and diabetes mellitus. The most spending for drugs were hemophilia, the nephritis group, nephrosis (mainly chronic renal failure), rheumatoid arthritis, breast cancer and AIDS. Priority diseases from the point of view of the services offered were those with high mortality and high disability. Conclusions. This is the first process of guidelines prioritizing in Peru. The first 5 diseases prioritized were: osteoarthritis, diabetes mellitus, glaucoma, chronic kidney disease and lumbago.

Palabras clave : Practice guideline; Disease; Peru.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons